Screening for NAFLD—Current Knowledge and Challenges

por Forlano, Roberta, Sigon, Giordano, Mullish, Benjamin H., Yee, Michael, Manousou, Pinelopi
Publicado 2023

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective

por Huang, Jian, Sigon, Giordano, Mullish, Benjamin H., Wang, Dan, Sharma, Rohini, Manousou, Pinelopi, Forlano, Roberta
Publicado 2023

THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD

por Izzi-Engbeaya, Chioma, Eng, Pei Chia, Dunin-Borkowska, Aleksandra, Forlano, Roberta, Mullish, Benjamin H, Sigon, Giordano, Lin, Vicky, Tan, Tricia, Yee, Michael, Manousou, Pinelopi, Dhillo, Waljit Singh
Publicado 2023

Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown

por Cinque, Felice, Cespiati, Annalisa, Lombardi, Rosa, Costantino, Andrea, Maffi, Gabriele, Alletto, Francesca, Colavolpe, Lucia, Francione, Paolo, Oberti, Giovanna, Fatta, Erika, Bertelli, Cristina, Sigon, Giordano, Dongiovanni, Paola, Vecchi, Maurizio, Fargion, Silvia, Fracanzani, Anna Ludovica
Publicado 2022

Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

por Lombardi, Rosa, Mura, Vincenzo La, Cespiati, Annalisa, Iuculano, Federica, Sigon, Giordano, Pallini, Giada, Proietti, Marco, Motta, Irene, Montinaro, Beatrice, Fiorelli, Elisa, Cesari, Matteo, Bandera, Alessandra, Valenti, Luca, Peyvandi, Flora, Montano, Nicola, Baldini, Marina, Fracanzani, Anna Ludovica
Publicado 2022

Correction to: Usefulness of Fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity

por Lombardi, Rosa, La Mura, Vincenzo, Cespiati, Annalisa, Iuculano, Federica, Sigon, Giordano, Pallini, Giada, Proietti, Marco, Motta, Irene, Montinaro, Beatrice, Fiorelli, Elisa, Cesari, Matteo, Bandera, Alessandra, Valenti, Luca, Peyvandi, Flora, Montano, Nicola, Baldini, Marina, Fracanzani, Anna Ludovica
Publicado 2022